Literature DB >> 14646359

Influence of murine renal sexual dimorphism on amiloride-induced hyperkalemia.

Asunción Cremades1, Vicente Vicente-Ortega, Rafael Peñafiel.   

Abstract

The present study investigated the influence of androgens in potassium homeostasis both under normal conditions and when potassium balance was affected by the mild diuretic amiloride. Our results indicate the existence of a clear sexual dimorphism in renal and plasma potassium content in CD1 mice, adult males having a higher plasma potassium concentration than females or 40-day-old male mice (4.6 +/- 1.0 vs. 3.9 +/- 0.9 mEq/l). Plasma K(+) concentration was increased by testosterone treatment and decreased after orchiectomy, while the opposite occurred in the case of renal potassium concentration. Amiloride was well tolerated by CD1 female mice, but induced severe hyperkalemia in male mice, where it was also associated with a high rate of mortality. Testosterone treatment increased the toxicity of the diuretic in both CD1 female and male mice. Histopathological analysis of kidneys from CD1 male mice treated with amiloride revealed alterations at the proximal and distal tubule level. These results strongly suggest that androgens may produce adverse effects in renal function. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14646359     DOI: 10.1159/000074331

Source DB:  PubMed          Journal:  Nephron Physiol        ISSN: 1660-2137


  2 in total

1.  SGK1-dependent ENaC processing and trafficking in mice with high dietary K intake and elevated aldosterone.

Authors:  Lei Yang; Gustavo Frindt; Florian Lang; Dietmar Kuhl; Volker Vallon; Lawrence G Palmer
Journal:  Am J Physiol Renal Physiol       Date:  2016-07-13

2.  Euthanasia by CO₂ inhalation affects potassium levels in mice.

Authors:  Ryan P Traslavina; Edward J King; Andrew S Loar; Elyn R Riedel; Michael S Garvey; Rodolfo Ricart-Arbona; Felix R Wolf; Suzana S Couto
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-05       Impact factor: 1.232

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.